SCHEMBL5391

SCHEMBL5391

CC(C)OC[C@]1(O)CC[C@]2(CCN(c3ccc(C(C)(C)C)cc3)C2)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 13/20 0.35
USP2 O75604 8/20 0.35
ALDH1A1 P00352 7/20 0.35
HSD17B10 Q99714 7/20 0.35
CYP2C9 P11712 6/20 0.35
CYP1A2 P05177 6/20 0.35
HIF1A Q16665 2/20 0.35
ALOX15 P16050 2/20 0.35
MAPK1 P28482 2/20 0.35
CYP2C19 P33261 7/20 0.34
TSHR P16473 3/20 0.34
MAPT P10636 3/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
HPGD P15428 2/20 0.33
LMNA P02545 1/20 0.33
CYP2D6 P10635 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5989 0.87 CYP3A4 (0.40) CYP3A4USP2ALDH1A1HSD17B10CYP2C9
SCHEMBL5651 0.81 LIPE (0.38) CYP3A4USP2ALDH1A1HSD17B10CYP2C9
SCHEMBL5548 0.80 CYP3A4 (0.36) CYP3A4USP2ALDH1A1HSD17B10CYP2C9
SCHEMBL5546 0.75 LIPE (0.44) CYP3A4USP2ALDH1A1HSD17B10CYP2C9
SCHEMBL4615 0.75 HSD11B1 (0.42) CYP3A4USP2ALDH1A1HSD17B10CYP2C9
SCHEMBL1589237 0.75 LIPE (0.57) ITGB3ITGA2B
SCHEMBL1589242 0.75 LIPE (0.57) ITGB3ITGA2B
SCHEMBL5611 0.75 CYP3A4 (0.40) CYP3A4USP2ALDH1A1HSD17B10CYP2C9
SCHEMBL25675738 0.74 HSD11B1 (0.40) CYP3A4USP2ALDH1A1HSD17B10CYP2C9
SCHEMBL25675741 0.71 HSD11B1 (0.40) CYP3A4USP2ALDH1A1HSD17B10CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed